Thursday, March 22, 2012
Merck & Co. Inc. has
traditionally formed external academic partnerships with labs working on projects
in areas of the pharma's direct interest. Now, Merck is expanding its early
stage academic outreach by investing up to $90 million over seven years to
found the not-for-profit California Institute for Biomedical Research, which
is focused on the translation of basic research into new medicines.
Cain, C. SciBX 5(12);
Published online March 22, 2012
1. Cain, C. SciBX 4(5);
2. Osherovich, L. SciBX 5(3);
3. Cain, C. SciBX 3(46);
AND INSTITUTIONS MENTIONED
5AM Ventures, Menlo Park, Calif.
Ambrx Inc., La Jolla, Calif.
California Institute for Biomedical Research, San Diego, Calif.
Genomics Institute of the Novartis Research Foundation, San Diego, Calif.
Harvard Medical School, Boston, Mass.
Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J.
Pfizer Inc. (NYSE:PFE), New York, N.Y.
The Scripps Research Institute, La Jolla, Calif.